Literature DB >> 16574382

The progesterone metabolite allopregnanolone potentiates GABA(A) receptor-mediated inhibition of 5-HT neuronal activity.

Vikas Kaura1, Colin D Ingram, Sarah E Gartside, Allan H Young, Sarah J Judge.   

Abstract

The dorsal raphe nucleus (DRN) is the origin of much of the 5-HT innervation of the forebrain. The activity of DRN 5-HT neurons is regulated by a number of receptors including GABA(A) and 5-HT(1A) inhibitory receptors and by excitatory alpha(1)-adrenoceptors. Using in vitro electrophysiological recording we investigated the action of progesterone and its metabolite, allopregnanolone on receptor-mediated responses of DRN 5-HT neurons. Neither allopregnanolone nor progesterone affected the alpha(1)-adrenoceptor agonist-induced firing. Allopregnanolone also had no effect on the inhibitory response to 5-HT. However, allopregnanolone significantly potentiated the inhibitory responses to GABA(A) receptor agonists. Progesterone did not enhance GABA(A) receptor-meditated inhibitory responses. Thus, the neuroactive metabolite of progesterone, allopregnanolone, has the ability to cause potentiation of GABA(A)-mediated inhibition of DRN 5-HT neurons. This effect on 5-HT neurotransmission may have relevance for mood disorders commonly associated with reproductive hormone events, such as premenstrual dysphoric disorder and postpartum depression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574382     DOI: 10.1016/j.euroneuro.2006.02.006

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  9 in total

1.  HOXA10 regulates endometrial GABAA {pi} receptor expression and membrane translocation.

Authors:  Homayoun Sadeghi; Hugh S Taylor
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-01-26       Impact factor: 4.310

Review 2.  The role of tryptophan metabolism in postpartum depression.

Authors:  Kai-Ming Duan; Jia-Hui Ma; Sai-Ying Wang; ZhengDong Huang; YingYong Zhou; HeYa Yu
Journal:  Metab Brain Dis       Date:  2018-01-06       Impact factor: 3.584

Review 3.  Emerging insights into hypothalamic-pituitary-gonadal axis regulation and interaction with stress signalling.

Authors:  A Acevedo-Rodriguez; A S Kauffman; B D Cherrington; C S Borges; T A Roepke; M Laconi
Journal:  J Neuroendocrinol       Date:  2018-08-07       Impact factor: 3.627

4.  Allopregnanolone reversion of estrogen and progesterone memory impairment: interplay with serotonin release.

Authors:  C Escudero; F Giuliani; M Mulle Bernedo; Roberto Yunes; R Cabrera
Journal:  J Neural Transm (Vienna)       Date:  2019-08-03       Impact factor: 3.575

Review 5.  Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?

Authors:  Claudio N Soares; Brook Zitek
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

Review 6.  Update on research and treatment of premenstrual dysphoric disorder.

Authors:  Joanne Cunningham; Kimberly Ann Yonkers; Shaughn O'Brien; Elias Eriksson
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

7.  Menstrual Cycle Phase Modulates Auditory-Motor Integration for Vocal Pitch Regulation.

Authors:  Xiaoxia Zhu; Yang Niu; Weifeng Li; Zhou Zhang; Peng Liu; Xi Chen; Hanjun Liu
Journal:  Front Neurosci       Date:  2016-12-27       Impact factor: 4.677

8.  Effects of exogenous melatonin on sleep and circadian rhythms in women with premenstrual dysphoric disorder.

Authors:  Christophe Moderie; Philippe Boudreau; Ari Shechter; Paul Lespérance; Diane B Boivin
Journal:  Sleep       Date:  2021-12-10       Impact factor: 6.313

9.  Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiol.

Authors:  Domenico De Berardis; Nicola Serroni; Rosa Maria Salerno; Filippo Maria Ferro
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.